Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

NCT00644735 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Erosive Esophagitis

Interventions

DRUG: Esomeprazole
DRUG: Lansoprazole

Sponsor

AstraZeneca